Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Genetic Testing is a Blessing: Cardiac Channelopathies Anjan S Batra, M.D Director of Electrophysiology Associate Professor of Pediatrics University of California-Irvine Common Inherited Diseases that Cause Sudden Arrhythmic Death Syndrome (SADS) z More than 50% of SADS deaths are genetic in nature.1 Reference: 1. Behr ER, Dalageorgou C, Christiansen M, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in majority of families. Eur Heart J. 2008;29:1670-1680. January 14-15, 2011 SCA Conference 1 The Family of Genetic Tests for Inherited Cardiac Syndromes Increased Awareness of and Improved Testing for LQTS Are Revealing a Higher Prevalence z Inherited LQTS is now known to affect 1:2,500 people.1 z It is estimated that 2,000-3,000 children and young adults die each year in the United States due to LQTS LQTS.2 References: 1. Crotti L, et al. Congenital long QT syndrome. Orphanet Journal of Rare Diseases. 2008;3:18. 2. Sudden Arrhythmia Death Syndromes (SADS) Foundation. LQTS brochure. Available at: http://www.sads.org. Accessed November 30, 2007. January 14-15, 2011 SCA Conference 2 Challenges in Diagnosing LQTS – ECG Variability z ~33% 33% off mutationt ti positive LQTS patients have a QT interval (≤ 480 msec) that overlaps normal, healthy individuals.2 Adapted from: Taggart NW, et al. Diagnostic miscues in congenital long-QT syndrome. Circulation. 2007;115:2613-2620.Cell. 2001;104:569-580. References: 1. Maron BJ, Moller JH, Seidman CE, et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome. Circulation. 1998;98:1460-1471. 2. Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long-QT syndrome. Circulation. 2007;115:2613-2620. Schwartz Score z Schwartz score results are frequently inconclusive 1 inconclusive. Probability Pts High 4 intermediate 2-3 Low 1 Reference: 1. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999;99:529-533. January 14-15, 2011 SCA Conference 3 THE BENEFITS OF GENETIC TESTING? Genetic Testing for Prevention Frequency of Cardiac Events Subjects from the International LQTS Registry & BIOMED LQTS Research Group January 14-15, 2011 SCA Conference 4 Gene Mutation Location Further Defines LQTS Risk z LQT1 LQT2 Adapted from: Moss AJ, et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007;115:2481-2489. Adapted from: Moss AJ, et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation. 2002;105:794-799. For LQT1 and LQT2 patients, there is significantly higher risk for cardiac events when mutations are located in the transmembrane/pore region.1,2 References: 1. Moss AJ, Shimizu W, Wilde AAM. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007;115:2481-2489. 2. Moss AJ, Zareba W, Kaufman ES, et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation. 2002;105:794-799. Examples of LQT1 and LQT2 Transmembrane Mutations KCNQ1/KvLQT1 KCNH2/HERG Genetic testing is the only method available to determine mutation location. January 14-15, 2011 SCA Conference 5 Risk for Asymptomatic Parents of Probands Risk of an Initial Cardiac Event for Asymptomatic Parents of Probands Extends Into Adulthood. Adapted from: Kimbrough J, Moss AJ, Zareba W, et al. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation. 2001;104:557-562. Reference: 1. Kimbrough J, Moss AJ, Zareba W, et al. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation. 2001;104:557-562. Genetic Testing for Therapy Effectiveness of β-Blocker Treatment Rate of cardiac events over five years for subjects from the International LQTS Registry Mohammed et al.J Cardiovasc Electrophysiol. 2007;18(7):791-797. January 14-15, 2011 SCA Conference 6 Genetic Testing for Therapy TEST RESULTS ISSUE DIRECTED THERAPY LQT 1 Experience events Avoid competitive sports. during exercise. Beta blocker therapy Endangered by exercise. advised. LQT 2 Auditory stimuli trigger events. Remove alarm clocks etc. from bedroom. Beta blocker therapy advised. LQT 3 Relatively low risk of exercise. High mortality rates despite beta blocker therapy. Supervised recreational activity could be considered. ICD therapy advised. Genetic Testing for Prognosis z LQT1 patients are more likely than either LQT2 or LQT3 patients to experience a cardiac event.1 z Although the incidence of cardiac events is lower for LQT3 patients, the probability of death per cardiac event is increased.1 Adapted from: Zareba W et al. Influence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med. 1998;339:14:960-965. Reference: 1. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med. 1998;339:14:960965. January 14-15, 2011 SCA Conference 7 Symptoms in CPVT z If left untreated, 30% of CPVT patients will develop symptoms by age 10, and ~80% by age 40.1 Adapted from: Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007;4:675-678. Reference: 1. Mohamed U, Napolitano C, Priori SG. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:791-797. Challenges in Diagnosing CPVT z CPVT cannot be diagnosed on the basis of a resting ECG.1,2 z Exercise stress testing is an important part of a CPVT workup. » However, in as many as 20% of CPVT patients, formal exercise stress testing will not produce ventricular ectopy ectopy.1 z During exercise stress testing, bidirectional VT with a beat-to-beat 180degree rotation of the QRS complex is often observed.1 References: 1. Mohamed U, Napolitano C, Priori SG. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:791-797. 2. Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights. Cardiovasc Res. 2005;67:379-387. January 14-15, 2011 SCA Conference 8 Differentiate CPVT from LQTS z z CPVT is a LQTS mimicker.1 As many as 30% of CPVT patients have been misdiagnosed as having “Long QT with normal QTc.”2,3 Genotyping Family Members of Known Probands Is Essential to Risk Management z All first-degree relatives, regardless of age, should be genotyped for the proband’s gene mutation(s).1,2,3 z An asymptomatic parent with an LQTS mutation has a high probability of having children at risk for cardiac events.1 z Approximately 33% of untreated siblings carry the proband’s gene mutation(s) and will have a cardiac event by 40 years of age.2 References: 1. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999;99:529-533. 2. Kimbrough J, Moss AJ, Zareba W, et al. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation. 2001;104:557-562. 3. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol. 2006;48:1065-1102. January 14-15, 2011 SCA Conference 9 CASE z A 12 year old boy passes out while swimming. He is appropriately resuscitated. The QTc on the ECG is 455 msec (indeterminate). Genetic testing comes back positive for long QT type 1. 1 » Subsequent genetic testing in his 8 year old sibling is positive but negative in the 6 year old sibling. Parents also undergo testing and the mother is found to be a carrier. Genetic testing in this scenario was helpful for which of the following? z A. The 12 year old boy B The B. Th 8 year old ld sibling ibli C. The 6 year old sibling D. Future offspring off all 3 children E. The parents z z z z Index Case (12 year old) z z z z z Probability of LQTS: » intermediate (Schwartz Score: 3) » High with genetic testing Therapy: » Initiate beta blockers but no need for ICD Prevention: » Limit strenuous activities activities. Prognosis: » good Helpful: » yes January 14-15, 2011 SCA Conference 10 8 year old sibling z Probability of LQTS: » intermediate (Schwartz Score: 2) » High with genetic testing (Positive family history and genotype positive) z Therapy: » Initiate beta blockers but no need for ICD z Prevention: » Limit strenuous activities. z P Prognosis: i » good z Helpful: » yes 6 year old sibling z Probability of LQTS: » intermediate (Schwartz Score: 2) » Low with genetic testing (Positive family history and genotype negative) z Therapy: » No need to initiate beta blockers or ICD z Prevention: » No limitations z Prognosis: » good z Helpful: » yes January 14-15, 2011 SCA Conference 11 Future offspring off all 3 children z z z Probability of LQTS: » Depends on genetic test of parent Recommendation » genetic testing for all offspring of genotype positive subjects but not of genotype negative subjects. subjects Helpful: » yes The Parents z z z z z Probability of LQTS: » High in mother » Low in father Recommend » genetic testing for all siblings of mother but not of father. Therapy: » Initiate beta blockers but no need for ICD Prognosis: » good Helpful: » yes January 14-15, 2011 SCA Conference 12 z z z z On 15 February 2006, 14 year old Shauna Stuewe was lost to Sudden Cardiac Arrest (SCA). An accomplished Gymnast and talented cheerleader, Shauna was both physically fit and the picture of health at the time her death. Shauna had been seen by a Pediatric Cardiologist who performed various tests including EKGs, Echocardiogram and Holter Monitor and concluded that Shauna was in good health, no further cardiac evaluation was needed and no restrictions were placed on her activities. Genetic autopsy testing on Shauna later revealed a gene mutation for CPVT. Her younger sister, who was also completely asympyomatic and an athlete, was subsequently found to be positive for CPVT by genetic testing. She now has an ICD. The Role of Genetic Testing January 14-15, 2011 SCA Conference 13 Questions Concerns with genetic testing z Cost Cost: » Make testing less expensive » bundle all channelopathy tests into one test. z Insurability » Universal insurance for all z Psychological trauma to families z False positives and false negatives » Availability of genetic councilors » Improve sensitivity and specificity of test z Significance of rare genotypes » Increase awareness of clinical significance of rare genotypes January 14-15, 2011 SCA Conference 14 Test Yield Channelopathy Sensitivity Long QT Syndrome (LQTS) 75% Brugada Syndrome 15-20% Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) 50-55% January 14-15, 2011 SCA Conference 15